Tuesday, March 12, 2013

Partnerships Featured Session: Case Study: Eli Lilly’s Clinical Open Innovation Initiative

The healthcare industry as a whole has adopted the practice of open innovation and although the pharmaceutical industry is the most risk averse group, Eli Lilly is pioneering an Open Innovation initiative. Along with companies such as Jansen, Pfizer and others, Lilly is on the forefront of data exchange and collaboration amongst both internal and external stakeholders.

Today we feature the Partnerships in Clinical Trials session of our most recent podcast participant, Thomas Krohn. For a preview of his session, download the PDF and MP3 of our most recent Inside Outsourcing podcast. If you'd like to know more about the program, download the agenda. Partnerships in Clinical Trials will take place April 21-24, 2013.  As a reader of this blog, when you register to join us and mention code XP1800BLOG, you'll save 15% off the standard rate!

Featured Presentation: Case Study: Eli Lilly’s Clinical Open Innovation Initiative

Featured Speaker: Thomas Krohn, Director, Clinical Open Innovation, Eli Lilly & Co.

About the session: The pharmaceutical industry is ripe with innovation opportunities. To find it, all the industry has to do is look outside its own walls. In recent years, a dramatic shift in the availability and use of information has occurred. Much of this shift, however, hasn’t been applied to the invention processes in life sciences, especially in contrast to other industries. Eli Lilly’s Clinical Open Initiative aims to seize this opportunity to reinvent invention through open innovation models and leveraging a framework called the Open Clinical Intelligence Network. In this case study presentation, you gain:
  • • Background to the Open Clinical Intelligence Network (OCIN)framework
  • • Insight into learning and value creation from our applied experiment portfolio
  • • Guidance and suggestions on how to engage in clinical open innovation




No comments: